Literature DB >> 9718253

5-HT2A receptor subtype is involved in the thermal hyperalgesic mechanism of serotonin in the periphery.

Atsushi Tokunaga1, Misako Saika, Emiko Senba.   

Abstract

The present study was designed to investigate which subtypes of 5-HT receptors are involved in 5-HT-induced hyperalgesia using behavioral assessment of hyperalgesia. 5-HT and various putative agonists for 5-HT receptor subtypes (5-HT(1A, 2, 3)) were intradermally injected into the rat ipsilateral hindpaw. Paw-withdrawal latency to radiant heat stimulation was examined every 15 min for 2 h. Injection of 5-HT (30 microg) and 5-HT2A receptor agonist (alpha-methyl 5-HT; 0.86 mg/kg) significantly reduced the paw-withdrawal latency. On the other hand, injection of 5-HT3 receptor agonists (2-methyl 5-HT; 0.86 mg/kg, m-CPG; 8 mg/kg) did not produce hyperalgesia. Furthermore, pretreatment with 5-HT2A receptor antagonist (ketanserin), but not with 5-HT3 receptor antagonist (tropisetron), attenuated the behavioral response after the injection of 5-HT. These findings strongly suggest that the 5-HT2A receptor subtype, but not the 5-HT3 subtype, is involved in 5-HT-induced hyperalgesia in acute injury and inflammation in the rat. In situ hybridization histochemistry revealed the presence of 5-HT2 receptor mRNA in a subpopulation of both large and small neurons in the rat dorsal root ganglia.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9718253     DOI: 10.1016/S0304-3959(98)00066-9

Source DB:  PubMed          Journal:  Pain        ISSN: 0304-3959            Impact factor:   6.961


  22 in total

1.  Responsiveness of C neurons in rat dorsal root ganglion to 5-hydroxytryptamine-induced pruritic stimuli in vivo.

Authors:  Junichi Hachisuka; Hidemasa Furue; Masutaka Furue; Megumu Yoshimura
Journal:  J Neurophysiol       Date:  2010-05-19       Impact factor: 2.714

2.  Anti-hyperalgesic effects of anti-serotonergic compounds on serotonin- and capsaicin-evoked thermal hyperalgesia in the rat.

Authors:  D R Loyd; P B Chen; K M Hargreaves
Journal:  Neuroscience       Date:  2011-12-20       Impact factor: 3.590

Review 3.  Candidate gene studies of fibromyalgia: a systematic review and meta-analysis.

Authors:  Young Ho Lee; Sung Jae Choi; Jong Dae Ji; Gwan Gyu Song
Journal:  Rheumatol Int       Date:  2010-12-01       Impact factor: 2.631

4.  Potentiation of transient receptor potential V1 functions by the activation of metabotropic 5-HT receptors in rat primary sensory neurons.

Authors:  Toshio Ohta; Yuki Ikemi; Matsuka Murakami; Toshiaki Imagawa; Ken-Ichi Otsuguro; Shigeo Ito
Journal:  J Physiol       Date:  2006-08-10       Impact factor: 5.182

Review 5.  Genetic polymorphism in pathogenesis of irritable bowel syndrome.

Authors:  Cynthia K Y Cheung; Justin C Y Wu
Journal:  World J Gastroenterol       Date:  2014-12-21       Impact factor: 5.742

6.  Inter-strain differences of serotonergic inhibitory pain control in inbred mice.

Authors:  Nina Wijnvoord; Boris Albuquerque; Annett Häussler; Thekla Myrczek; Laura Popp; Irmgard Tegeder
Journal:  Mol Pain       Date:  2010-10-26       Impact factor: 3.395

Review 7.  Serotonin in pain and analgesia: actions in the periphery.

Authors:  Claudia Sommer
Journal:  Mol Neurobiol       Date:  2004-10       Impact factor: 5.590

Review 8.  Serotonergic neuromodulation of peripheral nociceptors.

Authors:  Dayna R Loyd; Michael A Henry; Kenneth M Hargreaves
Journal:  Semin Cell Dev Biol       Date:  2012-09-19       Impact factor: 7.727

9.  Polymorphisms of the serotonin-2A receptor and catechol-O-methyltransferase genes: a study on fibromyalgia susceptibility.

Authors:  Berna Tander; Sezgin Gunes; Omer Boke; Gamze Alayli; Nurten Kara; Hasan Bagci; Ferhan Canturk
Journal:  Rheumatol Int       Date:  2008-01-15       Impact factor: 2.631

10.  Serotonin enhances urinary bladder nociceptive processing via a 5-HT3 receptor mechanism.

Authors:  Jason D Hall; Cary DeWitte; Timothy J Ness; Meredith T Robbins
Journal:  Neurosci Lett       Date:  2015-08-03       Impact factor: 3.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.